Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 100 Total
EVRI - Everi Holdings Inc - Stock Price Chart
TickerEVRI [NYSE, RUT]
CompanyEveri Holdings Inc
CountryUSA
IndustryGambling
Market Cap684.13MEPS (ttm)0.90
P/E9.04EPS this Y-2.71%
Forward P/E8.18EPS next Y12.61%
PEG0.45EPS past 5Y40.40%
P/S0.84EPS next 5Y20.00%
P/B3.02EPS Q/Q-92.47%
Dividend10.29%Sales Q/Q-6.36%
Insider Own3.10%Inst Own93.89%
Insider Trans-3.35%Inst Trans-1.68%
Short Float5.30%EarningsMay 08/b
Analyst Recom1.86Target Price12.43
Avg Volume1.15M52W Range7.99 - 17.85
Everi Holdings, Inc. engages in the provision of technology solutions to the casino, interactive, and gaming industry. It operates through the Games and Financial Technology Solutions (FinTech) segments. The Games segment focuses on leased gaming equipment, sales of gaming equipment, gaming systems, interactive solutions, and ancillary products and services. The FinTech segment provides access to cash at gaming facilities via ATM cash withdrawals, credit card cash access transactions and point of sale debit card cash access transactions, check-related services, fully integrated kiosks and maintenance services, compliance, audit and data software, casino credit data, and reporting services and other ancillary offerings. The company was founded on February 4, 2004 and is headquartered in Las Vegas, NV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
VALLI TODD A.SVP, CAOMay 02 '24Option Exercise6.5915,00098,85064,440May 02 09:37 PM
VALLI TODD A.SVP, CAOMay 02 '24Sale8.0515,000120,75049,440May 02 09:37 PM
Simmons DarrenEVP, FinTech Business LeaderMay 01 '24Option Exercise6.5945,000296,550197,550May 02 09:34 PM
Simmons DarrenEVP, FinTech Business LeaderMay 01 '24Sale8.0745,000363,150152,550May 02 09:34 PM
JUDGE GEOFFREY PDirectorApr 30 '24Option Exercise6.5930,000197,700121,572May 02 09:39 PM
UMBF - UMB Financial Corp. - Stock Price Chart
TickerUMBF [NASD, RUT]
CompanyUMB Financial Corp.
CountryUSA
IndustryBanks - Regional
Market Cap3.99BEPS (ttm)7.54
P/E10.86EPS this Y1.70%
Forward P/E9.22EPS next Y7.21%
PEG-EPS past 5Y12.81%
P/S1.58EPS next 5Y-
P/B1.27EPS Q/Q18.85%
Dividend1.92%Sales Q/Q25.92%
Insider Own6.37%Inst Own88.69%
Insider Trans-4.95%Inst Trans-0.48%
Short Float1.37%EarningsApr 30/a
Analyst Recom1.83Target Price95.50
Avg Volume285.76K52W Range50.68 - 87.36
UMB Financial Corp. engages in the provision of bank and asset services. It operates through the following segments: Commercial Banking, Institutional Banking, and Personal Banking. The Commercial Banking segment serves the commercial lending and leasing, capital markets, and treasury management needs of the company's mid-market businesses and governmental entities by offering various products and services. The Institutional Banking segment is a combination of banking services, fund services, and asset management services provided to institutional clients. The Personal Banking segment combines consumer banking and wealth management services offered to clients and delivered through personal relationships and the firm's bank branches, ATM network, and internet banking. The company was founded was founded in 1967 and is headquartered in Kansas City, MO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KEMPER J MARINERChairman and CEOMay 01 '24Sale79.665,400430,1701,733,204May 02 08:39 PM
KEMPER J MARINERChairman and CEOMay 01 '24Sale80.354,708378,2811,728,496May 02 08:42 PM
KEMPER J MARINERChairman and CEOMay 01 '24Sale80.563,790305,3371,724,706May 02 09:33 PM
KEMPER J MARINERChairman and CEOMay 01 '24Sale80.722,302185,8211,722,404May 02 09:36 PM
KEMPER J MARINERChairman and CEOApr 01 '24Sale84.9813,1301,115,8331,749,774Apr 03 04:46 PM
VKTX - Viking Therapeutics Inc - Stock Price Chart
TickerVKTX [NASD, RUT]
CompanyViking Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap8.35BEPS (ttm)-0.93
P/E-EPS this Y-21.98%
Forward P/E-EPS next Y-38.74%
PEG-EPS past 5Y-18.89%
P/S-EPS next 5Y40.00%
P/B8.94EPS Q/Q-6.06%
Dividend-Sales Q/Q-
Insider Own8.08%Inst Own68.58%
Insider Trans-8.10%Inst Trans-0.29%
Short Float11.00%EarningsApr 24/a
Analyst Recom1.09Target Price112.26
Avg Volume6.52M52W Range8.28 - 99.41
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mancini MariannaChief Operating OfficerMay 01 '24Option Exercise6.18281,4251,740,575629,933May 02 09:27 PM
Mancini MariannaChief Operating OfficerMay 01 '24Sale78.66281,42522,136,474348,508May 02 09:27 PM
Lian BrianPresident & CEOFeb 09 '24Sale29.9045,0001,345,5002,139,882Feb 09 08:59 PM
Lian BrianPresident & CEOFeb 08 '24Option Exercise3.76189,079711,3672,404,882Feb 08 07:40 PM
Rouan Sarah KathrynDirectorFeb 08 '24Option Exercise8.3225,000208,00025,000Feb 08 07:38 PM
AKRO - Akero Therapeutics Inc - Stock Price Chart
TickerAKRO [NASD, RUT]
CompanyAkero Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap1.36BEPS (ttm)-2.85
P/E-EPS this Y-33.21%
Forward P/E-EPS next Y-12.11%
PEG-EPS past 5Y1.03%
P/S-EPS next 5Y-14.60%
P/B2.05EPS Q/Q-100.87%
Dividend-Sales Q/Q-
Insider Own16.42%Inst Own82.58%
Insider Trans0.21%Inst Trans18.45%
Short Float14.16%EarningsFeb 29/b
Analyst Recom1.20Target Price48.89
Avg Volume1.41M52W Range11.25 - 58.38
Akero Therapeutics, Inc. is a clinical-stage company, which engages in the development of treatments for patients with serious metabolic diseases. The firm's lead product candidate, efruxifermin (EFX), is an analog of fibroblast growth factor 21, or FGF21, which is an endogenously expressed hormone that protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. The company was founded by Jonathan Young and Timothy Rolph in January 2017 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Young JonathanChief Operating OfficerMay 01 '24Sale20.155,000100,750258,306May 02 09:07 PM
Young JonathanChief Operating OfficerApr 01 '24Sale24.385,000121,913263,306Apr 03 06:55 PM
Cheng AndrewPresident and CEOMar 13 '24Sale28.331,96955,782589,447Mar 15 04:43 PM
White William RichardChief Financial OfficerMar 13 '24Sale28.3372420,51149,630Mar 15 04:44 PM
Yale CatrionaChief Development OfficerMar 13 '24Sale28.3372320,48377,692Mar 15 04:45 PM
FRGE - Forge Global Holdings Inc - Stock Price Chart
TickerFRGE [NYSE, RUT]
CompanyForge Global Holdings Inc
CountryUSA
IndustrySoftware - Application
Market Cap348.23MEPS (ttm)-0.52
P/E-EPS this Y22.29%
Forward P/E-EPS next Y28.60%
PEG-EPS past 5Y-
P/S4.99EPS next 5Y-
P/B1.30EPS Q/Q3.60%
Dividend-Sales Q/Q13.30%
Insider Own41.98%Inst Own27.70%
Insider Trans-0.49%Inst Trans14.57%
Short Float4.17%EarningsMay 07/a
Analyst Recom2.33Target Price3.88
Avg Volume824.97K52W Range1.10 - 4.02
Forge Global Holdings, Inc. engages in providing marketplace infrastructure, data services, and technology solutions for private market participants. It also offers a financial services platform, proprietary data, and insights to inform investment strategies. The company was founded in 2014 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rodriques KellyChief Executive OfficerMay 02 '24Sale1.9314,25427,53910,387,708May 02 08:59 PM
Rodriques KellyChief Executive OfficerMay 01 '24Sale1.8835,74667,32810,401,962May 02 08:59 PM
Rodriques KellyChief Executive OfficerApr 16 '24Sale1.8420,80338,19410,437,708Apr 18 05:57 PM
Rodriques KellyChief Executive OfficerApr 02 '24Sale1.7325,00043,26010,589,550Apr 03 06:09 PM
Rodriques KellyChief Executive OfficerApr 01 '24Sale1.8425,00046,04010,614,550Apr 03 06:09 PM
NFLX - Netflix Inc. - Stock Price Chart
TickerNFLX [NASD, NDX, S&P 500]
CompanyNetflix Inc.
CountryUSA
IndustryEntertainment
Market Cap243.56BEPS (ttm)14.41
P/E39.21EPS this Y52.90%
Forward P/E25.43EPS next Y20.84%
PEG1.42EPS past 5Y35.03%
P/S6.97EPS next 5Y27.67%
P/B11.40EPS Q/Q83.05%
Dividend-Sales Q/Q14.95%
Insider Own0.96%Inst Own82.98%
Insider Trans-9.55%Inst Trans3.04%
Short Float1.51%EarningsApr 18/a
Analyst Recom1.94Target Price654.66
Avg Volume3.65M52W Range315.62 - 639.00
Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HASTINGS REEDExecutive ChairmanMay 01 '24Option Exercise68.0918,3611,250,12218,389May 02 08:32 PM
Sweeney Anne MDirectorMay 01 '24Option Exercise178.49633112,982633May 02 08:43 PM
HASTINGS REEDExecutive ChairmanMay 01 '24Sale551.5418,36110,126,77728May 02 08:32 PM
Sweeney Anne MDirectorMay 01 '24Sale560.00633354,4800May 02 08:43 PM
Sweeney Anne MDirectorApr 30 '24Option Exercise189.802,377451,1642,377May 02 08:43 PM
ORCL - Oracle Corp. - Stock Price Chart
TickerORCL [NYSE, S&P 500]
CompanyOracle Corp.
CountryUSA
IndustrySoftware - Infrastructure
Market Cap315.97BEPS (ttm)3.78
P/E30.38EPS this Y9.14%
Forward P/E18.66EPS next Y10.23%
PEG2.84EPS past 5Y29.43%
P/S6.02EPS next 5Y10.71%
P/B56.16EPS Q/Q24.70%
Dividend1.34%Sales Q/Q7.11%
Insider Own41.91%Inst Own43.76%
Insider Trans-0.28%Inst Trans0.28%
Short Float0.82%EarningsMar 11/a
Analyst Recom1.97Target Price140.09
Avg Volume8.46M52W Range93.85 - 132.77
Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CONRADES GEORGE HDirectorMay 01 '24Option Exercise42.0225,0001,050,50042,836May 02 08:35 PM
CONRADES GEORGE HDirectorMay 01 '24Sale116.1325,0002,903,19017,836May 02 08:35 PM
CATZ SAFRAChief Executive OfficerMar 27 '24Option Exercise40.47810,00032,779,1201,928,592Mar 27 07:02 PM
CATZ SAFRAChief Executive OfficerMar 27 '24Sale125.06810,000101,294,6081,118,592Mar 27 07:02 PM
CATZ SAFRAChief Executive OfficerMar 26 '24Option Exercise39.89790,00031,513,1001,908,592Mar 27 07:02 PM
CDMO - Avid Bioservices Inc - Stock Price Chart
TickerCDMO [NASD, RUT]
CompanyAvid Bioservices Inc
CountryUSA
IndustryBiotechnology
Market Cap520.54MEPS (ttm)-0.29
P/E-EPS this Y-3275.00%
Forward P/E-EPS next Y40.94%
PEG-EPS past 5Y-
P/S3.81EPS next 5Y15.00%
P/B2.89EPS Q/Q-1416.67%
Dividend-Sales Q/Q-11.06%
Insider Own1.11%Inst Own95.04%
Insider Trans5.54%Inst Trans6.49%
Short Float16.44%EarningsApr 24/a
Analyst Recom1.40Target Price12.50
Avg Volume1.37M52W Range4.07 - 18.86
Avid Bioservices, Inc. engages in clinical and commercial manufacturing of biologics. It focuses on the biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. It specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Green Nicholas StewartPresident & CEOApr 30 '24Sale7.4011,76287,028203,606May 02 08:20 PM
Hart Daniel RChief Financial OfficerApr 30 '24Sale7.402,82620,91082,221May 02 08:20 PM
Ziebell Mark RV. P., General CounselApr 30 '24Sale7.401,64312,15764,834May 02 08:21 PM
Kwietniak Matthew R.Chief Commercial OfficerApr 30 '24Sale7.401,2339,12221,797May 02 08:20 PM
Richieri Richard A.Chief Operations OfficerApr 30 '24Sale7.401,0057,43627,132May 02 08:21 PM
RS - Reliance Inc. - Stock Price Chart
TickerRS [NYSE]
CompanyReliance Inc.
CountryUSA
IndustrySteel
Market Cap16.70BEPS (ttm)21.40
P/E13.58EPS this Y-12.43%
Forward P/E14.50EPS next Y1.23%
PEG3.77EPS past 5Y20.94%
P/S1.15EPS next 5Y3.60%
P/B2.10EPS Q/Q-18.73%
Dividend1.44%Sales Q/Q-8.08%
Insider Own0.75%Inst Own81.11%
Insider Trans-21.45%Inst Trans-4.55%
Short Float1.19%EarningsApr 25/b
Analyst Recom2.25Target Price355.38
Avg Volume273.31K52W Range229.12 - 342.20
Reliance, Inc. engages in the provision of a metal distribution center. It offers alloy, aluminum, brass, copper, carbon steel, stainless steel, titanium, and specialty steel products. The company was founded by Thomas J. Neilan on February 3, 1939, and is headquartered in Scottsdale, AZ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HOFFMAN JAMES DONALDDirectorApr 30 '24Sale289.815,0001,449,06749,042May 02 07:50 PM
Ajemyan ArthurSVP, CFOMar 06 '24Sale322.953,000968,85015,577Mar 06 05:36 PM
HOFFMAN JAMES DONALDDirectorFeb 27 '24Sale322.9540,00012,917,86754,042Feb 28 06:56 PM
Lewis Karla RPresident, CEOFeb 20 '24Sale318.9742,34613,507,13884,534Feb 21 07:24 PM
Lewis Karla RPresident, CEOFeb 16 '24Sale322.96650209,92483,884Feb 21 07:24 PM
PGNY - Progyny Inc - Stock Price Chart
TickerPGNY [NASD, RUT]
CompanyProgyny Inc
CountryUSA
IndustryHealth Information Services
Market Cap3.09BEPS (ttm)0.62
P/E51.99EPS this Y12.19%
Forward P/E32.14EPS next Y43.46%
PEG3.69EPS past 5Y-
P/S2.84EPS next 5Y14.10%
P/B5.55EPS Q/Q292.08%
Dividend-Sales Q/Q25.95%
Insider Own13.90%Inst Own87.29%
Insider Trans-4.87%Inst Trans-1.63%
Short Float7.95%EarningsMay 09/a
Analyst Recom1.10Target Price47.10
Avg Volume860.52K52W Range29.44 - 44.95
Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments. It operates through one segment: fertility and pharmacy benefits solutions. It also delivers treatment services and access to the firm's network of fertility specialist. The company was founded on April 3, 2008 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Payson NormanDirectorNov 23 '24Sale56.2920011,258580,656Nov 26 04:34 PM
Sturmer Michael EPRESIDENTMay 01 '24Sale31.954,515144,254380,038May 02 07:05 PM
Livingston Mark S.CHIEF FINANCIAL OFFICERApr 01 '24Option Exercise3.9520,62781,47772,875Apr 03 05:16 PM
Schlanger David JExecutive ChairmanApr 01 '24Option Exercise3.951,0003,95087,312Apr 03 05:27 PM
Livingston Mark S.CHIEF FINANCIAL OFFICERApr 01 '24Sale37.6211,165419,97950,119Apr 03 05:16 PM
12345678910